Immunometabolism is a branch dealing at the interface of immune functionalities and metabolic regulations. Considered as a bidirectional trafficking, metabolic contents and their precursors bring a considerable change in immune cells signal transductions which as a result affect the metabolic organs and states as an implication.
| INTRODUCTION
Immune cells are known as a diverse population within the human system that can adopt volatility from their quiescent phase as they get activated by various infections and inflammations. Metabolism is sole source of energy for cells, which they extract from available nutrients in the microenvironment. These cells in turn utilise this energy to perform their vital functions. Interestingly, microenvironment remains virtually same for static cells but obviously keeps changing in case of more dynamic ones such as immune cells which require to circulate to ensure immune surveillance. 1 The subtle change in microenvironment of immune cells makes them more plastic and adoptable metabolically. The change in metabolic scenario which is ever more consistent for immune cells brings degree of change in their inherent functionalities. Intriguingly immune cells are not only restricted to carry out attack against foreign bodies upon activation but also perform homeostatic roles during normalcy. 2 Metabolic changes within immune cells are definitely one of the factors for pro-inflammatory and anti-inflammatory biases.
Immunity and metabolism are critical determinants of each other as increasing evidence are suggesting the link between these two vital systems of human body. 3 Even within the immune cells there
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are distinct metabolic pathways which changes, reshape and adapt according to the given environment. These metabolic pathways within immune cells become vital for their own survival when they traverse to deeper tissues and forced to reside in an environment largely different where they had matured. 1 The Leptin receptor (Ob-R) manifests sequence homology to class I cytokine receptor (gp130) superfamily, 21 for example, IL-6, granulocyte colony-stimulating factor (G-CSF) and leucocyte inhibitory factor (LIF). It is reported to induce JAK-STAT, PI3K and MAPK signalling pathways. 22 Depletion or deficiency of leptin has been reported to cause inefficient phagocytosis and phenotypic abnormalities in macrophages, 23, 24 while alters the production of cytokines from Kupffer Cells (KCs). 25 Similarly, in dendritic cells leptin is a recognised producer of IL-8, IL-12, IL-6 and TNF-α, while it reduces MIP-1-α secretion. 26 Likewise, this metabolic hormone affects the functions of mast cells, 27 neutrophils 28 and Natural Killer (NK)
Cells. 29 Leptin deficiency is associated with increased susceptibility to damaging effects of TNF-α and LPS, 30, 31 which may be attributed to the lower number of circulating monocytes in ob-ob mice. Atherosclerosis is rather more relevant to Immunometabolism because this disease, over the course of decades, have acquired the reputation as a metabolic state as well as immune complication. It's a disease that occurs at the interface of immunity and metabolism and hence become a vital case study in this context. 39, 40 It is wellestablished now that metabolic reprogramming of glucose, fatty acids and amino acids in macrophages leads to fatal consequences in atherosclerosis. 41 Macrophages bind to the activated endothelial wall and transverse to the intimal layer where they expedite the uptake F I G U R E 1 Molecular interactions in Immunometabolism governing lipid metabolic disorders. Induction of Leptin receptor, GF receptors, TLR receptors and CD36 receptors lead to the activation of STAT3, mTORC1, XBP-1 (through IRE-1α) and HIF-1α that steer to interference in lipid metabolism. Additionally, mitochondria also respond to high-fat contents and divide the pyruvate pathway into lactate and OXPHOS that ultimately decide the inflammatory fate of oxidized low-density lipoprotein (oxLDL) and orchestrate the syn- which modulates HIF-1α that raises the GLUT-1 expression to increase the uptake of glucose within macrophages ( Figure 1 ). 44, 45 As discussed earlier, pro-inflammatory M1 choose glycolysis as preferential energy getting path. This scenario allows M1 macrophages to not only pick greater amount of glucose, sapping down host's energy but also serves as a stimulator to secrete more inflammatory cytokines. In one of the classic study Ldlr(−/−) mice were transplanted with bone marrow from HIF-1α deficient mice within the myeloid cells, which resulted in 72% reduction in atherosclerosis.
Similarly HIF-1α deficient macrophages manifested reduced differentiation to pro-inflammatory M1 macrophages. 44 HIF-1α also facilitates macrophages migration into tissues through activating pyruvate dehydrogenase kinase isozyme 1 (PDK1), which divert the glycolysis towards the formation of lactate (Figure 1) . 46 This proves the imper- and non-obese asthma patients through spirometry, body composition assessment by dual energy X-ray absorptiometry and found raised levels of sCD163 in former. The study also found elevated plasma CRP and leptin levels in obese asthma adults, while serum tryptase concentrations remained unchanged across different age groups of obese individuals. Finally, it concluded the higher existence of subphenotypes of macrophages in obese asthma patients at the molecular level. 49 Earlier sCD163 have been positively associated with body mass index (BMI) and type 2 diabetes as well. 50 A refined study in this context is conducted by Lessard 64 In addition to the involvement of macrophages and mast cells, the Immunometabolism in neutrophils is also indicated in obese asthma patients. 65, 66 For instance, traditional treatment of asthma responded to lesser degree in obese asthma patients in the presence of neutrophilic airway inflammation. 67 Another landmark study was reported by Scott et al in which obese and non-obese adults with asthma, and obese and non-obese healthy controls were compared by analysing neutrophil percentage and C-reactive protein level. Sputum neutrophil percentage and severity of neutrophilic asthma was positively found to be correlated with BMI and obesity. In conclusion, saturated and monounsaturated fatty acids were put as vital predictors of neutrophilic airway inflammation in asthma. 68 Parallel effects of saturated fatty acids were found on lung macrophages along with airways inflammation in mice when fed with high diet. 69 However it remains debatable that whether obstructive sleep apnoea or asthma is responsible for neutrophilic inflammation in obese cases. 70, 71 Excellent reviews on Immunometabolism are written in current years. 72, 73 WANG ET AL. Not all the studies have favoured the conventional anti-tumour role of Tregs within TME. For example, Whiteside have demarcated
Tregs into "good" and "bad" ones, the phenomenon, she states, depends on the in situ molecular pathways. 84 It is now believed that internal metabolism of cancer cells not only helps support the malignant growth but also affects malignant cells phenotype. 85 The residency of different malignant phenotypes in the presence of dissimilar immune cells within TME is a well reported evidence. 86 Giving a more specific perspective, Rydén et al implicated lipolysis
and exonerating inflammation, cell death and lipogenesis in adipose tissue loss in CC. However, study was still able to manifest IL-6 as a contributing factor. 98 Results were previously sup- 
